<SEC-DOCUMENT>0001193125-21-014727-index.html : 20210122
<SEC-HEADER>0001193125-21-014727.hdr.sgml : 20210122
<ACCEPTANCE-DATETIME>20210122161124
ACCESSION NUMBER:		0001193125-21-014727
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20210122
DATE AS OF CHANGE:		20210122
EFFECTIVENESS DATE:		20210122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akebia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001517022
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208756903
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-252336
		FILM NUMBER:		21545913

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-2098

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d116469ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d116469ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d116469dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d116469dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d116469dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d116469dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g116469ex51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g116469ex51.jpg

</DOCUMENT>
</SEC-DOCUMENT>